Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06116396

Liquid Biospy for Urinary Cancers

Use of Urinary Tumor Cells and Circulating Tumor Cells (CTCs) in the Prognosis and Therapy of Patients With Bladder (BCa) and Upper Urinary Tract (UTUC) Cancer"

Status
Recruiting
Phase
Study type
Observational
Enrollment
450 (estimated)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

The project aims to characterize the prognostic role of CTCs in Bladder cancer patients, with the specific aims to better stratify patients with non-muscle invasive bladder cancer at the first transurethral resection of tumor and to identify urothelial biomarker expressed by CTCs.

Detailed description

Bladder cancer (BCa) is the 9th most common cancer worldwide, with an estimated prevalence of around 2.7 million cases and an incidence around 350.000 new cases/year. The proper management of BCa remains an unmet clinical need, because one of the main problems in BCa treatment is the inability to efficaciously prevent high-grade non-muscle invasive bladder cancer (NMIBC) relapse and progression, which occur in 80% and 45% of patients respectively. Indeed, as a consequence of the lack of efficient established prognostic, diagnostic and predictive biomarker of high-risk NMIBC, Bca patients undergo multiple treatments and cystoscopic assessments along their life, with consequent poor quality of life and high healthcare costs. Circulating Tumor Cells (CTCs) in blood represent an invaluable source of tumor material that can be easily collected yhrough a simple blood draw and may represent the clonal component of the primary tumor that left the primary site. For this reason, the aim of this study is to characterize the prognostic role of CTCs in Bladder cancer patients, with the specific aims to better stratify patients with non-muscle invasive bladder cancer at the first transurethral resection of tumor and to identify urothelial biomarker expressed by CTCs.

Conditions

Interventions

TypeNameDescription
GENETICGenetic analysis on isolated cellsIsolation of cells from blood and urine

Timeline

Start date
2020-09-29
Primary completion
2025-09-29
Completion
2028-09-29
First posted
2023-11-03
Last updated
2023-11-07

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06116396. Inclusion in this directory is not an endorsement.